Document is current
Any future updates will be listed below
-
Authors
Azevedo Coste, Christine
Guiho, Thomas
Ferreira, Fernanda
Bailly, François
Degeorge, Benjamin
Geffrier, Antoine
Andreu, David
Teissier, Jacques
Guiraud, David
Fattal, Charles
-
Funding
Funding for this research was provided by:
Région Occitanie Grant (#14352)
EIT Health Grant (#20682)
EIC PathFinder (#101099916 AI-Hand)
- License Information
-
More Information
Article History
Received: 13 October 2025
Accepted: 17 December 2025
First Online: 14 January 2026
Declarations
:
: The protocol was approved by the French Ethics Committee (CPP Ouest IV Nantes, France, ID-RCB #2019-A00808-49, CPP Ouest II Angers, France ID-RCB 2022-A00205-38) and French Health Agency (ANSM). The study was registered on ClinicalTrials.gov, registration numbers: NCT04306328 and NCT05555914.
: Consent for publication was given by all participants.
: David Guiraud and David Andreu are shareholders of Neurinnov company.
